neamine, which is identical to the deacylated product obtained from butirosin A.
In the course of a search for new antibiotics produced by bacteria, a water-soluble, basic antibiotic, which was differentiated from the related known antibiotics by means of chromatographic, electrophoretic, and bioautographic comparison, was isolated. The structure of this antibiotic was determined to be 5-l-Dxylofuranosylneamine, and the antibiotic was tentatively named xylostasin.
Shortly afterwards, this same compound was described as a chemical degradation product of butirosin A by Tsukiura et al. (9) and Haskell et al. (4) . This paper deals with the fermentation process, isolation, characterization, and structural elucidation of xylostasin.
MATERIALS AND METHODS Organism. Bacillus sp. V-7 (ATCC 21933; American Type Culture Collection, Rockville, Md.) and Bacillus sp. Y-399 (ATCC 21932) were isolated from soil samples collected at Tokyo and Kyoto in Japan, respectively, and used for the production of xylostasin. Bacillus sp. V-7 belongs, to Bacillus circulans, whereas Bacillus sp. Y-399 differs from B. circulans in at least pigmentation and utilization of carbohydrates and shows a marked resemblance to B. vitellinus which was described as a butirosin producer by Hasegawa et al. (3) .
Fermentation. A loopful of cells grown on a glycerin-bouillon agar was used to inoculate a 2-liter shaking flask containing 500 ml of a sterile medium (pH 7.2) composed of 3% peptone, 1% meat extract, and 0.5% sodium chloride. The flask was incubated on a reciprocal shaker at 28 C for 24 h.
One liter of inoculum from these cultures was transferred to a 30-liter seed fermentor containing 20 liters of the same medium. The cultivation was carried out at 28 C for 24 h under agitation at 200 rpm and aeration of 20 liters per min. Ten liters of the seed culture broth thus obtained was transferred to a 200-liter fermentor containing 100 liters of the sterile medium (pH 7.5) composed of 2% dextrin, 1% peptone, 0.7% meat extract, 0.5% MgSO4 .7H1O, and 0.05% antifoam agent (Actcol, Takeda Chemical Industries, Ltd.). The fermentor was aerated at 100 liters per min and stirred at 200 rpm at 28 C for 66 h.
Assay. Samples obtained during the fermentation and purification procedures were assayed by a paperdisk agar-diffusion method using B. subtilis PCI 219 as a test organism and crystalline xylostasin base as a standard.
Dextrin was determined by the method of Dubois et al. (2) .
Bacterial growth was measured on absorbancy of a 10-fold diluted broth at 650 nm.
Isolation. Prior to filtering, 850 g of Primafloc C-7 (Rohm & Hass Co.) and 850 g of Hyflo-Super-Cel (Johns-Manville Products Co.) were added to the whole broth. The filtrate was passed through a column containing 5 liters of Amberlite IRC-50 (NH4+ form). The resin was eluted with 5% aqueous ammonia. The active effluent fractions were pooled and run onto a column of 2 liters of activated carbon. The carbon column was eluted with 0.3 N hydrochloric acid. The active fractions were neutralized with Amberlite IR-45 (OH-form) and the antibiotics were adsorbed on a column of 500 ml of Amberlite CG-50 (NH4+ form). After washing with water, the column was eluted with 0.2 N ammonia water. The active fractions were collected and concentrated under reduced pressure. The concentrate was allowed to stand overnight in a refrigerator to give crystalline xylostasin as free base. Thin-layer chromatographic and high-voltage paper electrophoretic analyses indicated it. to be homogeneous.
RESULTS AND DISCUSSION
The time course of a typical fermentation by Bacillus sp. Y-399 is given in Fig. 1 (c 1, H20); nuclear magnetic resonance (NMR), (D20); 6 1.33 (q, 1 H, axial methylene), 6 2.1 (m, 1 H, equatorial methylene) 6 5.43 (1 H, J = <1, anomeric proton), and 6 5.61 (d, 1 H, J = 3.5, anomeric proton); infrared spectrum (KBr), 3,320, 2,920, 1,590, 1,465, 1,340, 1,100 and 1,020 cm 1, but no absorption in the 1,640 to 1,650 cm-region (no -NH-CO-group); ultraviolet spectrum (H20), no maximum except end-absorption. The antimicrobial spectrum of xylostasin by the agar dilution method is shown in Table 1 . Xylostasin was cross-resistant with neomycin and kanamycin, and its spectrum was similar to that of ribostamycin (1, 6, 7) . Xylostasin (free base) has mean lethal dose in mice of 1,000 mg/kg intravenously, and mice infected with Escherichia coli 0-111 were protected by 1 to 10 mg/kg by the subcutaneous route.
Mild acid hydrolysis of xylostasin (0.5 N H2SO at 90 C for 6 h) gave D-xylose, [a]D " +19.40 (c 1, H20), which was identified by automatic liquid chromatography, gas liquid chromatography (as a per-trimethylsilylated sugar), paper electrophoresis, and paper chromatography. Methanolysis of xylostasin (1 N HCl in MeOH at 22 C for 6 days) gave neamine and methyl D-xyloside.
Xylostasin gave neamine, but no 4-amino-2-hydroxybutyric acid by strong acid hydrolysis (6 N HCI at 100 C for 16 h), whereas butirosin A (10-12) gave both neamine and 4-amino-2-hydroxybutyric acid, which was analyzed by using an amino acid autoanalyzer and by gas liquid chromatography (as a per-trimethylsilylated amino acid).
In thin-layer chromatography (Silica Gel G) using the upper phase of chloroform- 
